It’s a great news for Brittany biotechnologies domain. Biotrial opens a new site in USA to grow up its capacity for phase 1 studies. The Newark site will perform up to 50 studies per year ! Congratulation Biotrial.

According to Francois Peaucelle, General Manager, Biotrial, the company has started activities with studies for European and American biotech, the pharma industry, and US generics companies.

Source: Biotrial: transparency key as CRO moves forward in US


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply